Description |
lipoprotein(a) |
fibronectin 1 |
Image |
No pdb structure |
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Aortic valve stenosis ( 29511194)
- Aortic-valve calcification ( 23388002)
- Blood protein levels ( 28240269)
- Body mass index ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Cholesterol, total ( 24097068 28270201 25961943 20686565)
- Coronary artery disease ( 29212778 24262325 30104761 26343387 28714974)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- Coronary artery disease in diabetes ( 30003307)
- Coronary artery disease or ischemic stroke ( 24262325)
- Coronary artery disease or large artery stroke ( 24262325)
- Coronary heart disease ( 19198611 21378990)
- End stage renal disease x APOL1 genotype interaction ( 29885931)
- HDL cholesterol ( 25961943 20686565)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Heart failure ( 31919418)
- Ischemic stroke (large artery atherosclerosis) ( 29531354)
- LDL cholesterol ( 24097068 30275531 25961943 20686565)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Lipid or lipoprotein levels ( 23696881)
- Lipoprotein (a) levels ( 26377243 30108283 28512139)
- Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention) ( 31186284)
- Lipoprotein phospholipase A2 activity in cardiovascular disease ( 28753643)
- Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms ( 28512139)
- Lipoprotein-associated phospholipase A2 activity change in response to statin therapy ( 23118302)
- Lp (a) levels ( 21900290 19124843)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (antithrombotic agents) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Medication use (salicylic acid and derivatives) ( 31015401)
- Medication use (vasodilators used in cardiac diseases) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolite levels (lipoprotein measures) ( 27005778)
- Minimum ankle–brachial index ( 31285632)
- Monocyte early outgrowth colony forming units ( 21493818)
- Myocardial infarction ( 26343387)
- Parental lifespan ( 29030599)
- Parental longevity (both parents in top 10%) ( 29227965)
- Parental longevity (combined parental age at death) ( 29227965)
- Parental longevity (combined parental attained age, Martingale residuals) ( 29227965)
- Parental longevity (father's age at death) ( 31484785 29227965)
- Parental longevity (father's attained age) ( 29227965)
- Parental longevity (mother's age at death or mother's attained age) ( 31484785)
- Parental longevity (mother's age at death) ( 29227965)
- Parental longevity (mother's attained age) ( 29227965)
- Peripheral artery disease ( 31285632)
- Plasma plasminogen levels ( 25208887)
- Protein quantitative trait loci ( 18464913)
- Response to statin therapy ( 22368281)
- Response to statins (LDL cholesterol change) ( 25350695 22331829)
- Total cholesterol levels ( 28334899 30275531)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglycerides ( 30275531 25961943)
|
|
Interacting Genes |
9 interacting genes:
APOH
CANX
CELA1
ELANE
FBLN5
FGB
FN1
LRP2
MMP12
|
103 interacting genes:
ADAMTS4
AMBP
ANOS1
APCS
ATXN10
ATXN7
C1QA
CCN3
CD44
CDKN2A
COL13A1
COL1A1
COL1A2
COL2A1
COL4A1
COL4A2
COL4A3
COL4A4
COL4A5
COL4A6
COL6A2
COL7A1
COMP
CRP
CTSD
CXCL12
DCN
DUSP10
EGFR
F13A1
FAM86B3P
FASLG
FBLN1
FBLN2
FST
FSTL3
GALNT6
GRB2
GSN
HGF
HRG
HSPG2
IGFBP3
IGFBP5
ITGA2B
ITGA3
ITGA4
ITGA5
ITGA8
ITGB1
ITGB3
ITGB6
ITGB7
KLK3
KPNA2
LACRT
LGALS3BP
LPA
LRG1
LTBP1
MAG
MATN2
MEP1A
MEP1B
MIA
MMP9
MTDH
MTNR1A
MYOC
NPTX1
NR0B2
NT5E
PELI2
PKD1
PLAT
PLG
PRELP
PRPF40A
RARA
RBL1
REG3A
RPS6KA5
SCGB1A1
SDC2
SKIL
SMAD4
SMAD9
SPARC
STAT5A
TAB1
TAB2
TAC1
TGFBI
TGM2
THBS1
TIMD4
TMPRSS6
TNC
TNFRSF11B
TSHR
UBQLN1
VEGFA
VHL
|
Entrez ID |
4018 |
2335 |
HPRD ID |
01063 |
00626 |
Ensembl ID |
ENSG00000198670
|
ENSG00000115414
|
Uniprot IDs |
|
B7ZLE5
P02751
Q6MZF4
Q6MZM7
Q6N084
Q9UQS6
|
PDB IDs |
|
1E88
1E8B
1FBR
1FNA
1FNF
1FNH
1J8K
1O9A
1OWW
1Q38
1QGB
1QO6
1TTF
1TTG
2CG6
2CG7
2CK2
2CKU
2EC3
2FN2
2FNB
2GEE
2H41
2H45
2HA1
2MNU
2N1K
2OCF
2RKY
2RKZ
2RL0
3CAL
3EJH
3GXE
3M7P
3MQL
3R8Q
3T1W
3ZRZ
4GH7
4JE4
4JEG
4LXO
4MMX
4MMY
4MMZ
4PZ5
5DC0
5DC4
5DC9
5DFT
5J6Z
5J7C
5M0A
5N47
5N48
6HNF
6MFA
6MSV
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|